Neuronal transport defects of the MAP6 KO mouse - a model of schizophrenia - and alleviation by Epothilone D treatment, as observed using MEMRI

NeuroImage

Volumn 96, Issue , 2014, Pages 133-142

  Daoust, Alexia ^a,b   Bohic, Sylvain ^a,b,c   Saoudi, Yasmina ^a,b,d   Debacker, Clément ^a,b,e   Gory Fauré, Sylvie ^a,b,d   Andrieux, Annie ^a,b,d   Barbier, Emmanuel Luc ^a,b   Deloulme, Jean Christophe ^a,b,d  

^a GRENOBLE INSTITUT DES NEUROSCIENCES   (France)

^b UNIV GRENOBLE ALPES   (France)

^c EUROPEAN SYNCHROTRON RADIATION FACILITY   (France)

^d DIF   (France)

^e BRUKER BIOSPIN GMBH   (Germany)

Author keywords

Epothilone D; Manganese; MAP6; MEMRI; Neuronal tract

Indexed keywords

EPOTHILONE D; MANGANESE; MANGANESE CHLORIDE; MICROTUBULE ASSOCIATED PROTEIN 6; PEPTIDES AND PROTEINS; UNCLASSIFIED DRUG; CONTRAST MEDIUM; EPOTHILONE DERIVATIVE; MICROTUBULE ASSOCIATED PROTEIN; TUBULIN MODULATOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC DRUG ADMINISTRATION; CONNECTOME; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DISEASE MODEL; EXPERIMENTAL MODEL; FEMALE; KNOCKOUT MOUSE; MOUSE; NERVE FIBER TRANSPORT; NEUROANATOMICAL TRACT TRACING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIMARY SOMATOSENSORY CORTEX; PRIORITY JOURNAL; SCHIZOPHRENIA; SYNAPTIC TRANSMISSION; WHITE MATTER; WILD TYPE; ANIMAL; C57BL MOUSE; DIAGNOSTIC USE; DRUG EFFECTS; GENETICS; HUMAN; METABOLISM; PATHOPHYSIOLOGY; PROCEDURES; SOMATOSENSORY CORTEX; TREATMENT OUTCOME;

ANIMALS; CONTRAST MEDIA; DISEASE MODELS, ANIMAL; EPOTHILONES; HUMANS; MAGNETIC RESONANCE IMAGING; MANGANESE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROTUBULE-ASSOCIATED PROTEINS; SCHIZOPHRENIA; SOMATOSENSORY CORTEX; SYNAPTIC TRANSMISSION; TREATMENT OUTCOME; TUBULIN MODULATORS;

EID: 84899847968     PISSN: 10538119     EISSN: 10959572     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2014.03.071     Document Type: Article

References (57)

1. Andrieux A., Salin P.A., Vernet M., Kujala P., Baratier J., Gory-Fauré S., Bosc C., Pointu H., Proietto D., Schweitzer A., Denarier E., Klumperman J., Job D. The suppression of brain cold-stable microtubules in mice induces synaptic defects associated with neuroleptic-sensitive behavioral disorders. Genes Dev. 2002, 16:2350-2364.
2. Andrieux A., Salin P., Schweitzer A., Begou M., Pachoud B., Brun P., Gory-Faure S., Kujala P., Suaud-Chagny M.F., Hofle G., Job D. Microtubule stabilizer ameliorates synaptic function and behavior in a mouse model for schizophrenia. Biol. Psychiatry 2006, 60:1224-1230.
3. Barten D.M., Fanara P., Andorfer C., Hoque N., Wong P.Y., Husted K.H., Cadelina G.W., Decarr L.B., Yang L., Liu V., Fessler C., Protassio J., Riff T., Turner H., Janus C.G., Sankaranarayanan S., Polson C., Meredith J.E., Gray G., Hanna A., Olson R.E., Kim S.H., Vite G.D., Lee F.Y., Albright C.F. Hyperdynamic microtubules, cognitive deficits, and pathology are improved in tau transgenic mice with low doses of the microtubule-stabilizing agent BMS-241027. J. Neurosci. 2012, 32:7137-7145.
4. Bearer E.L., Falzone T.L., Zhang X., Biris O., Rasin A., Jacobs R.E. Role of neuronal activity and kinesin on tract tracing by manganese-enhanced MRI (MEMRI). NeuroImage 2007, 37(SUPPL. 1):S37-S46.
5. Bearer E.L., Zhang X., Janvelyan D., Boulat B., Jacobs R.E. Reward circuitry is perturbed in the absence of the serotonin transporter. NeuroImage 2009, 46:1091-1104.
6. Bégou M., Volle J., Bertrand J.B., Brun P., Job D., Schweitzer A., Saoud M., D'Amato T., Andrieux A., Suaud-Chagny M.F. The stop null mice model for schizophrenia displays cognitive and social deficits partly alleviated by neuroleptics. Neuroscience 2008, 157:29-39.
7. Bertrand A., Khan U., Hoang D.M., Novikov D.S., Krishnamurthy P., Rajamohamed Sait H.B., Little B.W., Sigurdsson E.M., Wadghiri Y.Z. Non-invasive, in vivo monitoring of neuronal transport impairment in a mouse model of tauopathy using MEMRI. NeuroImage 2013, 64:693-702.
8. Bouvrais-Veret C., Weiss S., Andrieux A., Schweitzer A., McIntosh J.M., Job D., Giros B., Martres M.P. Sustained increase of alpha7 nicotinic receptors and choline-induced improvement of learning deficit in STOP knock-out mice. Neuropharmacology 2007, 52:1691-1700.
9. Brenner E., Sonnewald U., Schweitzer A., Andrieux A., Nehlig A. Hypoglutamatergic activity in the STOP knockout mouse: a potential model for chronic untreated schizophrenia. J. Neurosci. Res. 2007, 85:3487-3493.
10. Brun P., Begou M., Andrieux A., Mouly-Badina L., Clerget M., Schweitzer A., Scarna H., Renaud B., Job D., Suaud-Chagny M.F. Dopaminergic transmission in STOP null mice. J. Neurochem. 2005, 94:63-73.
11. Brunden K.R., Zhang B., Carroll J., Yao Y., Potuzak J.S., Hogan A.M., Iba M., James M.J., Xie S.X., Ballatore C., Smith A.B., Lee V.M., Trojanowski J.Q. Epothilone D improves microtubule density, axonal integrity, and cognition in a transgenic mouse model of tauopathy. J. Neurosci. 2010, 30:13861-13866.
12. Costas J., Suarez-Rama J.J., Carrera N., Paz E., Paramo M., Agra S., Brenlla J., Ramos-Rios R., Arrojo M. Role of DISC1 interacting proteins in schizophrenia risk from genome-wide analysis of missense SNPs. Ann. Hum. Genet. 2013, 77:504-512.
13. De Vos K.J., Chapman A.L., Tennant M.E., Manser C., Tudor E.L., Lau K.F., Brownlees J., Ackerley S., Shaw P.J., McLoughlin D.M., Shaw C.E., Leigh P.N., Miller C.C., Grierson A.J. Familial amyotrophic lateral sclerosis-linked SOD1 mutants perturb fast axonal transport to reduce axonal mitochondria content. Hum. Mol. Genet. 2007, 16:2720-2728.
14. Delotterie D., Ruiz G., Brocard J., Schweitzer A., Roucard C., Roche Y., Suaud-Chagny M.F., Bressand K., Andrieux A. Chronic administration of atypical antipsychotics improves behavioral and synaptic defects of STOP null mice. Psychopharmacology (Berl.) 2010, 208:131-141.
15. Drapeau P., Nachshen D.A. Manganese fluxes and manganese-dependent neurotransmitter release in presynaptic nerve endings isolated from rat brain. J. Physiol. 1984, 348:493-510.
16. Fitzsimmons J., Kubicki M., Smith K., Bushell G., Estepar R.S., Westin C.F., Nestor P.G., Niznikiewicz M.A., Kikinis R., McCarley R.W., Shenton M.E. Diffusion tractography of the fornix in schizophrenia. Schizophr. Res. 2009, 107:39-46.
17. Fournet V., Jany M., Fabre V., Chali F., Orsal D., Schweitzer A., Andrieux A., Messanvi F., Giros B., Hamon M., Lanfumey L., Deloulme J.C., Martres M.P. The deletion of the microtubule-associated STOP protein affects the serotonergic mouse brain network. J. Neurochem. 2010, 115:1579-1594.
18. Fournet V., de Lavilleon G., Schweitzer A., Giros B., Andrieux A., Martres M.P. Both chronic treatments by epothilone D and fluoxetine increase the short-term memory and differentially alter the mood-status of STOP/MAP6 KO mice. J. Neurochem. 2012, 123:982-996.
19. Fradley R.L., O'Meara G.F., Newman R.J., Andrieux A., Job D., Reynolds D.S. STOP knockout and NMDA NR1 hypomorphic mice exhibit deficits in sensorimotor gating. Behav. Brain Res. 2005, 163:257-264.
20. Friocourt G., Marcorelles P., Saugier-Veber P., Quille M.L., Marret S., Laquerriere A. Role of cytoskeletal abnormalities in the neuropathology and pathophysiology of type I lissencephaly. Acta Neuropathol. 2011, 121:149-170.
21. Gallagher J.J., Zhang X., Ziomek G.J., Jacobs R.E., Bearer E.L. Deficits in axonal transport in hippocampal-based circuitry and the visual pathway in APP knock-out animals witnessed by manganese enhanced MRI. NeuroImage 2012, 60:1856-1866.
22. Jouroukhin Y., Ostritsky R., Assaf Y., Pelled G., Giladi E., Gozes I. NAP (davunetide) modifies disease progression in a mouse model of severe neurodegeneration: protection against impairments in axonal transport. Neurobiol. Dis. 2013, 56:79-94.
23. Kim J., Choi I.Y., Michaelis M.L., Lee P. Quantitative in vivo measurement of early axonal transport deficits in a triple transgenic mouse model of Alzheimer's disease using manganese-enhanced MRI. NeuroImage 2011, 56:1286-1292.
24. Leergaard T.B., Bjaalie J.G., Devor A., Wald L.L., Dale A.M. In vivo tracing of major rat brain pathways using manganese-enhanced magnetic resonance imaging and three-dimensional digital atlasing. NeuroImage 2003, 20:1591-1600.
25. Lutkenhoff E., Karlsgodt K.H., Gutman B., Stein J.L., Thompson P.M., Cannon T.D., Jentsch J.D. Structural and functional neuroimaging phenotypes in dysbindin mutant mice. NeuroImage 2012, 62:120-129.
26. Merenlender-Wagner A., Pikman R., Giladi E., Andrieux A., Gozes I. NAP (davunetide) enhances cognitive behavior in the STOP heterozygous mouse-a microtubule-deficient model of schizophrenia. Peptides 2010, 31:1368-1373.
27. Morello M., Canini A., Mattioli P., Sorge R.P., Alimonti A., Bocca B., Forte G., Martorana A., Bernardi G., Sancesario G. Sub-cellular localization of manganese in the basal ganglia of normal and manganese-treated rats: an electron spectroscopy imaging and electron energy-loss spectroscopy study. Neurotoxicology 2008, 29:60-72.
28. Narita K., Kawasaki F., Kita H. Mn and Mg influxes through Ca channels of motor nerve terminals are prevented by verapamil in frogs. Brain Res. 1990, 510:289-295.
29. Palau-Baduell M., Salvadó-Salvadó B., Clofent-Torrentó M., Valls-Santasusana A. Autism and neural connectivity. Rev. Neurol. 2012, 54(SUPPL. 1):S31-S39.
30. Pastor M.T., Kummerer N., Schubert V., Esteras-Chopo A., Dotti C.G., Lopez de la Paz M., Serrano L. Amyloid toxicity is independent of polypeptide sequence, length and chirality. J. Mol. Biol. 2008, 375:695-707.
31. Patterson J.V., Hetrick W.P., Boutros N.N., Jin Y., Sandman C., Stern H., Potkin S., Bunney W.E. P50 sensory gating ratios in schizophrenics and controls: a review and data analysis. Psychiatry Res. 2008, 158:226-247.
32. Pautler R.G. In vivo, trans-synaptic tract-tracing utilizing manganese-enhanced magnetic resonance imaging (MEMRI). NMR Biomed. 2004, 17:595-601.
33. Pautler R.G., Koretsky A.P. Tracing odor-induced activation in the olfactory bulbs of mice using manganese-enhanced magnetic resonance imaging. NeuroImage 2002, 16:441-448.
34. Pautler R.G., Silva A.C., Koretsky A.P. In vivo neuronal tract tracing using manganese-enhanced magnetic resonance imaging. Magn. Reson. Med. 1998, 40:740-748.
35. Paxinos G., Watson C. The Rat Brain in Sterotaxic Coordinates 1998, Academic Press, San Diego.
36. Powell K.J., Hori S.E., Leslie R., Andrieux A., Schellinck H., Thorne M., Robertson G.S. Cognitive impairments in the STOP null mouse model of schizophrenia. Behav. Neurosci. 2007, 121:826-835.
37. Raponi E., Agenes F., Delphin C., Assard N., Baudier J., Legraverend C., Deloulme J.C. S100B expression defines a state in which GFAP-expressing cells lose their neural stem cell potential and acquire a more mature developmental stage. Glia 2007, 55:165-177.
38. Saleem K.S., Pauls J.M., Augath M., Trinath T., Prause B.A., Hashikawa T., Logothetis N.K. Magnetic resonance imaging of neuronal connections in the macaque monkey. Neuron 2002, 34:685-700.
39. Schmued L., Bowyer J., Cozart M., Heard D., Binienda Z., Paule M. Introducing Black-Gold II, a highly soluble gold phosphate complex with several unique advantages for the histochemical localization of myelin. Brain Res. 2008, 1229:210-217.
40. Sharp D.J., Ross J.L. Microtubule-severing enzymes at the cutting edge. J. Cell Sci. 2012, 125:2561-2569.
41. Smith K.D., Kallhoff V., Zheng H., Pautler R.G. In vivo axonal transport rates decrease in a mouse model of Alzheimer's disease. NeuroImage 2007, 35:1401-1408.
42. Smith K.D., Peethumnongsin E., Lin H., Zheng H., Pautler R.G. Increased human wildtype tau attenuates axonal transport deficits caused by loss of APP in mouse models. Magn. Reson. Insights 2010, 4:11-18.
43. Smith K.D., Paylor R., Pautler R.G. R-flurbiprofen improves axonal transport in the Tg2576 mouse model of Alzheimer's disease as determined by MEMRI. Magn. Reson. Med. 2011, 65:1423-1429.
44. Soria G., Wiedermann D., Justicia C., Ramos-Cabrer P., Hoehn M. Reproducible imaging of rat corticothalamic pathway by longitudinal manganese-enhanced MRI (L-MEMRI). NeuroImage 2008, 41:668-674.
45. Stokin G.B., Lillo C., Falzone T.L., Brusch R.G., Rockenstein E., Mount S.L., Raman R., Davies P., Masliah E., Williams D.S., Goldstein L.S. Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease. Science 2005, 307:1282-1288.
46. Szebenyi G., Morfini G.A., Babcock A., Gould M., Selkoe K., Stenoien D.L., Young M., Faber P.W., MacDonald M.E., McPhaul M.J., Brady S.T. Neuropathogenic forms of huntingtin and androgen receptor inhibit fast axonal transport. Neuron 2003, 40:41-52.
47. Takeda A., Kodama Y., Ishiwatari S., Okada S. Manganese transport in the neural circuit of rat CNS. Brain Res. Bull. 1998, 45:149-152.
48. Taya S., Shinoda T., Tsuboi D., Asaki J., Nagai K., Hikita T., Kuroda S., Kuroda K., Shimizu M., Hirotsune S., Iwamatsu A., Kaibuchi K. DISC1 regulates the transport of the NUDEL/LIS1/14-3-3epsilon complex through kinesin-1. J. Neurosci. 2007, 27:15-26.
49. Tucciarone J., Chuang K.H., Dodd S.J., Silva A., Pelled G., Koretsky A.P. Layer specific tracing of corticocortical and thalamocortical connectivity in the rodent using manganese enhanced MRI. NeuroImage 2009, 44:923-931.
50. Van der Linden A., Verhoye M., Van Meir V., Tindemans I., Eens M., Absil P., Balthazart J. In vivo manganese-enhanced magnetic resonance imaging reveals connections and functional properties of the songbird vocal control system. Neuroscience 2002, 112:467-474.
51. Volle J., Brocard J., Saoud M., Gory-Faure S., Brunelin J., Andrieux A., Suaud-Chagny M.F. Reduced expression of STOP/MAP6 in mice leads to cognitive deficits. Schizophr. Bull. 2013, 39:969-978.
52. von Bartheld C.S., Cunningham D.E., Rubel E.W. Neuronal tracing with DiI: decalcification, cryosectioning, and photoconversion for light and electron microscopic analysis. J. Histochem. Cytochem. 1990, 38:725-733.
53. Wang F.H., Appelkvist P., Klason T., Gissberg O., Bogstedt A., Eliason K., Martinsson S., Briem S., Andersson A., Visser S.A., Ivarsson M., Lindberg M., Agerman K., Sandin J. Decreased axonal transport rates in the Tg2576 APP transgenic mouse: improvement with the gamma-secretase inhibitor MRK-560 as detected by manganese-enhanced MRI. Eur. J. Neurosci. 2012, 36:3165-3172.
54. Willemsen M.H., Vissers L.E., Willemsen M.A., van Bon B.W., Kroes T., de Ligt J., de Vries B.B., Schoots J., Lugtenberg D., Hamel B.C., van Bokhoven H., Brunner H.G., Veltman J.A., Kleefstra T. Mutations in DYNC1H1 cause severe intellectual disability with neuronal migration defects. J. Med. Genet. 2012, 49:179-183.
55. Yu X., Wadghiri Y.Z., Sanes D.H., Turnbull D.H. In vivo auditory brain mapping in mice with Mn-enhanced MRI. Nat. Neurosci. 2005, 8:961-968.
56. Yu X., Nieman B.J., Sudarov A., Szulc K.U., Abdollahian D.J., Bhatia N., Lalwani A.K., Joyner A.L., Turnbull D.H. Morphological and functional midbrain phenotypes in Fibroblast Growth Factor 17 mutant mice detected by Mn-enhanced MRI. NeuroImage 2011, 56:1251-1258.
57. Zhang B., Carroll J., Trojanowski J.Q., Yao Y., Iba M., Potuzak J.S., Hogan A.M., Xie S.X., Ballatore C., Smith A.B., Lee V.M., Brunden K.R. The microtubule-stabilizing agent, epothilone D, reduces axonal dysfunction, neurotoxicity, cognitive deficits, and Alzheimer-like pathology in an interventional study with aged tau transgenic mice. J. Neurosci. 2012, 32:3601-3611.